Investing.com - Bristol-Myers Squibb (NYSE:BMY) reported on Friday fourth quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Bristol-Myers Squibb announced earnings per share of $1.83 on revenue of $11.99B. Analysts polled by Investing.com anticipated EPS of $1.8 on revenue of $12.09B.
Bristol-Myers Squibb shares are up 2% from the beginning of the year and are trading at $64.07 , down-from-52-week-high.They are outperforming the S&P Global 100 which is down 2.77% from the start of the year.
Bristol-Myers Squibb follows other major Healthcare sector earnings this month
Bristol-Myers Squibb's report follows an earnings beat by UnitedHealth on Wednesday, January 19, 2022, who reported EPS of $4.48 on revenue of $73.74B, compared to forecasts EPS of $4.3 on revenue of $72.98B.
J&J had beat expectations on Tuesday, January 25, 2022 with fourth quarter EPS of $2.13 on revenue of $24.8B, compared to forecast for EPS of $2.12 on revenue of $25.28B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar